PEAK6 Group’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
$2.17M Buy
49,000
+47,800
+3,983% +$2.38M 0.01% 1308
2018
Q1
$58K Sell
1,200
-11,900
-91% -$595K ﹤0.01% 3916
2017
Q4
$656K Sell
13,100
-16,800
-56% -$880K ﹤0.01% 2259
2017
Q3
$1.51M Sell
29,900
-39,200
-57% -$1.85M 0.01% 1612
2017
Q2
$2.62M Buy
69,100
+11,600
+20% +$458K 0.02% 1129
2017
Q1
$2.21M Sell
57,500
-66,200
-54% -$1.99M 0.02% 1066
2016
Q4
$2.73M Buy
123,700
+67,000
+118% +$1.38M 0.02% 1075
2016
Q3
$907K Buy
56,700
+26,700
+89% +$305K 0.01% 1847
2016
Q2
$247K Sell
30,000
-43,800
-59% -$390K ﹤0.01% 2983
2016
Q1
$517K Buy
+73,800
New +$371K ﹤0.01% 2253

Other funds holding CC

PEAK6 Group's CC Position: Q2 2018 in Review

PEAK6 Group increased its Chemours (CC) stake by 25% in Q2 2018, buying an estimated $349K and bringing the position to 34,557 shares worth $1.53M. The position accounts for 0.01% of the portfolio, ranked #1587.

PEAK6 Group first reported a position in CC in Q3 2015 and has held it in 8 quarters since. 558 funds tracked by Wall St. Rank hold CC as of Q2 2018.

  • PEAK6 Group held 34,557 shares of Chemours worth $1.53M as of Q2 2018.
  • PEAK6 Group bought 7,010 Chemours shares in Q2 2018, an estimated $349K.
  • Chemours made up 0.01% of PEAK6 Group's portfolio in Q2 2018, its #1587 holding.
  • PEAK6 Group first reported a position in Chemours in Q3 2015 and has held it in 8 quarters since.
  • 558 funds tracked by Wall St. Rank held Chemours as of Q2 2018.

Based on PEAK6 Group's 13F filing for Q2 2018, filed 15 Aug 2018.